dallas semaglutide ileus law office gastric intestinal obstruction firm in Ozempic and Wegovy Manufacturers Accused of Downplaying Drugs' Risks in Product Liability Suit leading semaglutide side effect law
Description
This might include switching to another GLP-1 receptor agonist, adding or adjusting other oral hypoglycaemic agents, or considering injectable therapies such as insulin if appropriate, in line with NICE guidance (NG28)

7 , e2253 (2016)

Risk factors for hypoglycemia when taking Ozempic include combining the drug with other diabetes medications like insulin or sulfonylureas

Christine Albert is currently President of Heart Rhythm Society